The Anyfusion ACPi system for preparing injectable medications has been granted patents in Japan and China, securing international patent recognition. U.S.-based Company N has agreed to jointly develop a CSTD specifically for the Anyfusion ACPi system. Development of the CSTD and equipment will be completed this year. The system will offer 1,000cc/hr cartridge kit sets and 5,000cc cartridge kit sets, enabling medical institutions to handle daily preparation, This will be the world's only multifunctional equipment capable of handling all of the following with a single device: anticancer (injection) drug preparation, TPN preparation, PCA balloon anticancer drug filling, injection drug filling, and IV fluid administration.

Pricing per unit is estimated at 100-200 million KRW for the System model and 300-500 million KRW for the Pro model, depending on HIS integration status. Daily dispensing capacity is 100-120 cases for the System model and 300-400+ cases for the Pro model. With its favorable cost-performance ratio in terms of dispensing volume and price, it is expected to replace syringe-based robotic dispensing equipment, conventional dispensing equipment, and CSTDs.

We have agreed to negotiate and sign a contract with the CEO of US Company C, recommended by the Korean Embassy in the US, in Anaheim for consulting on the overall US business for Anyfusion Platform Items and EZ Regular. The first task is to pursue a major-level US partner for EZ Regular. Trump's high tariffs on Chinese imports are expected to create an opportunity.

All investment firms have completely shut down due to political, economic, and social uncertainties. Domestically, the healthcare crisis has prevented us from escaping deficits, leading to a halt in new equipment purchases. This situation should have ended last year, but if it persists into this year, the domestic market will likely remain challenging for the foreseeable future. We will activate opportunities in the US market and overseas markets like Saudi Arabia to meet stakeholders' expectations.

Thank you.